EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic - Orgenesis (NASDAQ:ORGS)

Orgenesis to acquire full ownership of Octomera & Metalmark to receive royalty & proceeds in exchange. Shift to decentralized production supported by regulators.

Related Keywords

Vered Caplan ,Orgenesis Inc ,Mm Os Holdings ,Metalmark Capital Partners ,